V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038504 | 210008064 | 1.79 | 47.45 | T | 2017-02-07 | 2017-02-17 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 210014595 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210038506 | 210019250 | null | 13.7 | Curative (C) | 2014-12-02 | 2015-08-10 | Alemtuzumab | N | N | 210014747 | ALEMTUZUMAB |
| 210038507 | 210008155 | null | null | Curative (C) | 2018-06-27 | 2018-09-10 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210014775 | UKALLR3 |
| 210038509 | 210008565 | 1.64 | null | Curative (C) | 2018-07-27 | 2018-08-13 | Venetoclax | 2 | N | 210015709 | VENETOCLAX |
| 210038510 | 210008646 | null | 47.45 | Curative (C) | 2015-07-22 | 2016-11-20 | Carboplatin AUC 2 - 5 | N | N | 210015905 | CARBOPLATIN |
| 210038511 | 210008768 | 1.75 | null | Curative (C) | 2016-10-28 | 2018-08-03 | LOMUSTINE + PROCARBAZINE | Y | N | 210016332 | LOMUSTINE + PROCARBAZINE |
| 210038512 | 210008925 | 1.67 | null | Disease modification (D) | 2019-05-17 | 2019-09-08 | Vinblastine weekly | Y | N | 210016939 | VINBLASTINE |
| 210038513 | 210019943 | 1.6 | 71.5 | Palliative (P) | 2019-01-20 | 2019-02-14 | CARBOPLATIN + VINCRISTINE | N | N | 210018518 | CARBOPLATIN + VINCRISTINE |
| 210038514 | 210009736 | 1.6 | 66.5 | Adjuvant (A) | 2017-10-23 | 2018-05-12 | Vinblastine | N | Y | 210019691 | VINBLASTINE |
| 210038515 | 210010805 | null | 41.5 | Palliative (P) | 2017-03-30 | 2017-04-07 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 210027036 | CARBOPLATIN + VINCRISTINE |
| 210038516 | 210010877 | 1.66 | 55.2 | Curative (C) | 2017-07-31 | 2017-12-15 | Brentuximab | Y | null | 210027529 | BEVACIZUMAB + IRINOTECAN |
| 210038517 | 210012143 | 1.65 | 56.3 | Curative (C) | 2015-03-03 | 2015-10-04 | GEM-P | null | N | 210033299 | ICE |
| 210038518 | 210012158 | 1.65 | 76.399 | Curative (C) | 2016-11-20 | 2017-03-24 | CARBOPLATIN + VINORELBINE | Y | N | 210033375 | FLUOROURACIL + RT |
| 210038519 | 210012304 | 1.62 | 66 | Curative (C) | 2018-07-06 | 2018-07-06 | DASATINIB + IDARUBICIN + VINCRISTINE | Y | null | 210034037 | CAPECITABINE + OXALIPLATIN |
| 210038520 | 210012320 | null | null | Curative (C) | 2018-07-21 | 2019-03-18 | CLL210 TRIAL | N | N | 210034115 | BR14 TRIAL |
| 210038521 | 210027729 | 1.91 | 72 | Palliative (P) | 2020-03-07 | 2020-11-09 | BOSUTINIB | null | Y | 210034702 | IRINOTECAN + TEMOZOLOMIDE |
| 210038522 | 210012788 | 1.89 | 97.7 | Curative (C) | 2014-07-11 | 2015-01-11 | IMMUNOGLOBULIN | 02 | N | 210037370 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE |
| 210038523 | 210027877 | 1.67 | 83.7 | Curative (C) | 2017-04-10 | 2018-10-21 | PEMBROLIZUMAB | N | N | 210037617 | CLOFARABINE + CYTARABINE |
| 210038524 | 210013149 | 0 | 69.3 | Curative (C) | 2020-10-23 | 2021-03-24 | Ofatumumab Weekly | N | N | 210039036 | CYCLO + FLUDARABINE + RITUXIMAB |
| 210038525 | 210013419 | 1.73 | 67.2 | Curative (C) | 2019-04-07 | 2019-04-28 | CTD Attenuated (Thalidomide 50mg) | N | N | 210040628 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210038526 | 210022451 | 1.63 | null | Disease modification (D) | 2016-05-04 | 2016-05-07 | Cytarabine intrathecal | Y | N | 210041021 | IBRUTINIB + RITUXIMAB |
| 210038527 | 210013790 | 1.52 | 80.05 | Disease modification (D) | 2019-09-25 | 2019-09-25 | Fludarabine + Melphalan RIC Allo | N | N | 210028705 | CYCLO + FLUDARABINE + RITUXIMAB |
| 210038528 | 210022752 | 1.87 | 60.8 | Curative (C) | 2019-09-23 | 2020-09-27 | Ofatumumab Weekly | Y | N | 210041781 | RCEOP |
| 210038529 | 210029401 | 1.65 | 61.8 | Not known (9) | 2015-06-19 | 2015-11-13 | Temozolomide 200mg/m2 | N | N | 210000122 | TEMOZOLOMIDE |
| 210038532 | 210004761 | 0 | null | Curative (C) | 2018-12-17 | 2019-04-08 | Temozolomide 150mg/m2 | N | N | 210002776 | TEMOZOLOMIDE |
| 210038533 | 210017530 | 1.77 | null | Adjuvant (A) | 2018-11-11 | 2018-11-11 | TEMOZOLOMIDE | 02 | N | 210004002 | TEMOZOLOMIDE |
| 210038534 | 210005064 | 1.75 | 49.4 | Palliative (P) | 2018-11-17 | 2018-11-21 | TEMOZOLOMIDE | 2 | null | 210004402 | TEMOZOLOMIDE |
| 210038535 | 210017578 | 1.57 | null | Palliative (P) | 2015-05-23 | 2015-05-27 | TEMOZOLOMIDE | N | N | 210004493 | TEMOZOLOMIDE |
| 210038536 | 210017633 | null | 98 | Adjuvant (A) | 2015-03-07 | 2015-03-07 | TEMOZOLOMIDE | N | N | 210005131 | TEMOZOLOMIDE |
| 210038537 | 210025022 | 1.75 | 96 | Adjuvant (A) | 2015-07-12 | 2015-08-11 | TEMOZOLOMIDE | 2 | N | 210005198 | TEMOZOLOMIDE |
| 210038538 | 210017661 | 1.69 | 76.5 | Palliative (P) | 2019-02-03 | 2019-02-03 | Temozolomide 200mg/m2 | N | N | 210005410 | TEMOZOLOMIDE |
| 210038540 | 210017670 | null | 13.7 | Curative (C) | 2018-01-14 | 2018-07-08 | ALL UKALL2011 Maintenance A1 | Y | null | 210005470 | UKALL2011 |
| 210038542 | 210017685 | 1.16 | 18.2 | Curative (C) | 2018-05-05 | 2018-12-08 | ALL UKALL2011 Maintenance A3 | Y | N | 210005614 | UKALL2011 |
| 210038543 | 210017741 | 1.52 | 19.8 | Curative (C) | 2015-10-14 | 2015-12-23 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | null | 210006133 | UKALL2011 |
| 210038544 | 210005476 | 0 | 10.4 | Curative (C) | 2017-11-13 | 2017-11-18 | ALL UKALL2011 Maintenance A3 | Y | null | 210006371 | UKALL2011 |
| 210038545 | 210025153 | null | 22.4 | Curative (C) | 2018-12-02 | 2019-09-13 | ALL UKALL2011 Maintenance C1 | null | N | 210006587 | UKALL2011 |
| 210038546 | 210029809 | 0 | 16.5 | Curative (C) | 2016-02-11 | 2016-07-19 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 210006602 | UKALL2011 |
| 210038547 | 210035892 | 1.88 | 40.2 | Curative (C) | 2014-05-27 | 2014-10-09 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 210006736 | UKALL2011 |
| 210038548 | 210005581 | 0 | 16.5 | Curative (C) | 2019-11-16 | 2020-11-22 | ALL UKALL2011 Maintenance A1 | Y | N | 210006833 | UKALL2011 |
| 210038549 | 210017830 | 1.47 | 95 | Curative (C) | 2019-04-10 | 2019-10-10 | ALL UKALL2011 Maintenance B2 | Y | N | 210006940 | UKALL2011 |
| 210038551 | 210005640 | null | 15.4 | Curative (C) | 2016-08-26 | 2017-05-29 | ALL UKALL2011 Del Int C Recon PAsp | N | null | 210007091 | UKALL2011 |
| 210038552 | 210025214 | null | 14.1 | Curative (C) | 2014-06-26 | 2015-01-30 | ALL UKALL2011 Maintenance A1 | Y | N | 210007149 | UKALL2011 |
| 210038553 | 210005673 | 1.3 | 16.8 | Curative (C) | 2016-01-12 | 2016-06-05 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 210007259 | UKALL2011 |
| 210038555 | 210005706 | 1.9 | 9.2 | null | 2018-05-22 | 2018-10-02 | ALL UKALL2011 Cap Int Maint C PAsp | Y | N | 210007468 | UKALL2011 |
| 210038556 | 210005760 | null | 30.4 | Curative (C) | 2014-08-19 | 2014-11-18 | ALL UKALL2011 Del Int A Pt1 (PAsp) | null | N | 210007627 | UKALL2011 |
| 210038557 | 210005803 | 1.52 | 30 | Curative (C) | 2014-11-25 | 2015-02-25 | ALL UKALL2011 Del Intens B Pt2 | Y | N | 210007768 | UKALL2011 |
| 210038558 | 210005849 | 1.31 | 22.4 | Curative (C) | 2015-05-09 | 2015-11-19 | ALL UKALL2011 Aug BFM Cons C PegAsp | N | N | 210007896 | UKALL2011 |
| 210038559 | 210005888 | 1.26 | 22.6 | Curative (C) | 2014-07-04 | 2014-08-14 | ALL UKALL2011 Del Intens B Pt2 | Y | N | 210008060 | UKALL2011 |
| 210038560 | 210018021 | 1.14 | 47.3 | Curative (C) | 2014-07-15 | 2014-10-26 | ALL UKALL2011 Maintenance A1 | Y | null | 210008074 | UKALL2011 |
| 210038562 | 210005936 | null | 19.7 | Curative (C) | 2017-08-13 | 2017-09-23 | ALL UKALL2011 Cap Int Maint C PAsp | N | null | 210008197 | UKALL2011 |